Mortality of continuous infusion versus intermittent bolus of meropenem: a systematic review and meta-analysis of randomized controlled trials

Mortality of continuous infusion versus intermittent bolus of meropenem: a systematic review and meta-analysis of randomized controlled trials

BackgroundMeropenem belongs to the carbapenem class, which is categorized as beta-lactam antibiotics. These antibiotics are administered in intermittent bolus doses at specific time intervals. However, the continuous infusion approach ensures sustained drug exposure, maintaining the drug concentrati...

Full description

Bibliographic Details
Main Authors:	Ming-Ying Ai, Wei-Lun Chang, Chia-Ying Liu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-03-01
Series:	Frontiers in Microbiology
Subjects:	continuous infusion meropenem mortality resistant pathogens bacterial eradication
Online Access:	https://www.frontiersin.org/articles/10.3389/fmicb.2024.1337570/full

Similar Items

Pharmacokinetic and Pharmacodynamic Efficacies of Continuous versus Intermittent Administration of Meropenem in Patients with Severe Sepsis and Septic Shock: A Prospective Randomized Pilot Study
by: Hui-Ying Zhao, et al.
Published: (2017-01-01)

Case report: Successful experience using continuous infusion of meropenem in a geriatric patient with hip fracture complicated by sepsis
by: Assiya Kadralinova, et al.
Published: (2023-04-01)

Model-Informed Translation of In Vitro Effects of Short-, Prolonged- and Continuous-Infusion Meropenem against <em>Pseudomonas aeruginosa</em> to Clinical Settings
by: Iris K. Minichmayr, et al.
Published: (2022-08-01)

Population Pharmacokinetics of Continuous-Infusion Meropenem in Febrile Neutropenic Patients with Hematologic Malignancies: Dosing Strategies for Optimizing Empirical Treatment against Enterobacterales and <i>P. aeruginosa</i>
by: Pier Giorgio Cojutti, et al.
Published: (2020-08-01)

Pathogen-based target attainment of optimized continuous infusion dosing regimens of piperacillin-tazobactam and meropenem in surgical ICU patients: a prospective single center observational study
by: Thomas De Corte, et al.
Published: (2023-04-01)

Extended Versus Intermittent Meropenem Infusion in the Treatment of Nosocomial Pneumonia: A Retrospective Single-Center Study
by: Dong-gon Hyun, et al.
Published: (2023-10-01)

Measuring Creatinine Clearance Is the Most Accurate Way for Calculating the Proper Continuous Infusion Meropenem Dose for Empirical Treatment of Severe Gram-Negative Infections among Critically Ill Patients
by: Carla Troisi, et al.
Published: (2023-02-01)

Extended Infusion of Meropenem in Neonatal Sepsis: A Historical Cohort Study
by: Guangna Cao, et al.
Published: (2022-03-01)

Successful Treatment of Bacteremia and Ventilator-Associated Pneumonia Caused by KPC/OXA-48-like <i>Klebsiella pneumoniae</i> Co-Producer with a Continuous Infusion of High-Dose Meropenem Plus Fosfomycin Guided by Real-Time Therapeutic Drug Monitoring
by: Pier Giorgio Cojutti, et al.
Published: (2022-01-01)

Effect of extended infusion of meropenem and nebulized amikacin on Gram-negative multidrug-resistant ventilator-associated pneumonia
by: Mona Ahmed Ammar, et al.
Published: (2018-01-01)

Bolus versus continuous infusion of nitroglycerin for the treatment of acute hypertensive heart failure
by: Mahmoud Shawky Abdelmoneum, et al.
Published: (2022-01-01)

Continuous infusion versus intermittent infusion of vancomycin in critically ill patients undergoing continuous venovenous hemofiltration: a prospective interventional study
by: Jinhui Xu, et al.
Published: (2022-08-01)

Impact of Maximizing Css/MIC Ratio on Efficacy of Continuous Infusion Meropenem Against Documented Gram-Negative Infections in Critically Ill Patients and Population Pharmacokinetic/Pharmacodynamic Analysis to Support Treatment Optimization
by: Pier Giorgio Cojutti, et al.
Published: (2021-12-01)

Meropenem PK/PD Variability and Renal Function: “We Go Together”
by: Jacopo Angelini, et al.
Published: (2023-08-01)

Stability of meropenem in portable elastomeric infusion devices: which protocol should be implemented in clinical practice?
by: Beatriz Esteban-Cartelle, et al.
Published: (2024-01-01)

Stability of meropenem in portable elastomeric infusion devices: which protocol should be implemented in clinical practice?
by: Beatriz Esteban-Cartelle, et al.
Published: (2024-02-01)

Comparison of continuous epidural infusion and programmed intermittent epidural bolus in labor analgesia
by: Lin Y, et al.
Published: (2016-07-01)

Real-Time TDM-Based Expert Clinical Pharmacological Advice Program for Attaining Aggressive Pharmacokinetic/Pharmacodynamic Target of Continuous Infusion Meropenem in the Treatment of Critically Ill Patients with Documented Gram-Negative Infections Undergoing Continuous Veno-Venous Hemodiafiltration
by: Milo Gatti, et al.
Published: (2023-10-01)

Software- and TDM-Guided Dosing of Meropenem Promises High Rates of Target Attainment in Critically Ill Patients
by: Ute Chiriac, et al.
Published: (2023-06-01)

Effectiveness of Extended or Continuous vs. Bolus Infusion of Broad-Spectrum Beta-Lactam Antibiotics for Febrile Neutropenia: A Systematic Review and Meta-Analysis
by: Kazuhiro Ishikawa, et al.
Published: (2023-06-01)

Continuous Vancomycin Infusion versus Intermittent Infusion in Critically Ill Patients
by: Maluangnon C, et al.
Published: (2022-12-01)

C/MIC > 4: A Potential Instrument to Predict the Efficacy of Meropenem
by: Yichang Zhao, et al.
Published: (2022-05-01)

Meropenem pharmacokinetics during relapsing peritonitis due to ESBL‐producing Enterobacteriaciae in a liver transplant recipient
by: Kensuke Shoji, et al.
Published: (2019-11-01)

Intrapleural Bupivacaine Analgesia: Bolus Versus Continuous Infusion Technique for Postoperative Pain Relief in Children
by: Hassan S Al-Khayat, et al.
Published: (2008-01-01)

Comparison of Endostar continuous versus intermittent intravenous infusion in combination with first‐line chemotherapy in patients with advanced non‐small cell lung cancer
by: Yuan Cheng, et al.
Published: (2019-07-01)

Combined Programmed Intermittent Bolus and Patient-Controlled Bolus Is a More Favorable Setting for Epidural Pain Relief Than Continuous Infusion
by: Shih-Kai Liu, et al.
Published: (2023-05-01)

Programmed Intermittent Epidural Bolus versus Continuous Epidural Infusion in Major Upper Abdominal Surgery: A Retrospective Comparative Study
by: Yeon-Ju Kim, et al.
Published: (2021-11-01)

Comparison of continuous infusion and bolus administration of tramadol in postoperative children
by: Jeanne-Roos Tikoalu, et al.
Published: (2016-09-01)

Combined Use of Vancomycin and Meropenem in Patient with Acute Intermittent Porphyria: A Case Report
by: İrfan ŞENCAN, et al.
Published: (2004-09-01)

Effect of Heparin on Coagulation Tests: A Comparison of Continuous and Bolus Infusion in Haemodialysis Patients
by: Ali Akbar Nasiri, et al.
Published: (2016-02-01)

A Mathematical Model for Comparison of Bolus Injection, Continuous Infusion, and Liposomal Delivery of Doxorubicin to Tumor Cells
by: Ardith W. El-Kareh, et al.
Published: (2000-07-01)

Pharmacokinetics and Pharmacodynamics of Meropenem by Extended or Continuous Infusion in Low Body Weight Critically Ill Patients
by: Sonia Luque, et al.
Published: (2021-06-01)

Continuous Versus Intermittent Linezolid Infusion for Critically Ill Patients with Hospital-Acquired and Ventilator-Associated Pneumonia: Efficacy and Safety Challenges
by: Ahmed E. Abou Warda, et al.
Published: (2022-02-01)

Pharmacokinetics of vancomycin and meropenem during continuous online hemodiafiltration: A case report
by: Yoko Niibe, et al.
Published: (2023-06-01)

Linezolid Administration to Critically Ill Patients: Intermittent or Continuous Infusion? A Systematic Literature Search and Review
by: Ligia-Ancuta Hui, et al.
Published: (2022-03-01)

Continuous wound infusion as an alternative to continuous epidural infusion for postoperative analgesia in renal transplant surgery: A prospective randomized controlled trial
by: Vinitha Narayan, et al.
Published: (2021-01-01)

Cerebrospinal Fluid Concentrations of Meropenem and Vancomycin in Ventriculitis Patients Obtained by TDM-Guided Continuous Infusion
by: Christoph Tiede, et al.
Published: (2021-11-01)

Extended infusion of β-lactams significantly reduces mortality and enhances microbiological eradication in paediatric patients: a systematic review and meta-analysisResearch in context
by: Kinga Anna Budai, et al.
Published: (2023-11-01)

Clinical outcomes of prolonged infusion (extended infusion or continuous infusion) versus intermittent bolus of meropenem in severe infection: A meta-analysis.
by: Zhenwei Yu, et al.
Published: (2018-01-01)

Clinical pharmacokinetics of 3-h extended infusion of meropenem in adult patients with severe sepsis and septic shock: implications for empirical therapy against Gram-negative bacteria
by: Amol T. Kothekar, et al.
Published: (2020-01-01)